Curis Inc (CRIS) reports reduced net loss and expenses, while advancing its emavusertib program with potential accelerated approvals..
Sports
Curis Inc (CRIS) Q4 2024 Earnings Call Highlights: Financial Improvements and Promising ...
Curis Inc (CRIS) reports reduced net loss and expenses, while advancing its emavusertib program with potential accelerated approvals.